Partner
Recombinant Production of Bioactive Compounds, High Throughput Drug Development, Transgenic Microorganisms and Plants, Pharmaceuticals, Medical Devices, Stem Cells, CRISPR, Biologics, Food Processing, Wireless Networks, Artificial Intelligence, Cloud Gaming, Augmented Reality
Scott is a recognized authority on the business and legal issues that arise at the intersection of intellectual property law and emerging technologies. He advises clients around the globe — from start-ups to Fortune 100 companies — on protecting, leveraging, and maximizing the value of their patent portfolios. His expertise includes portfolio and landscape analysis, licensing, litigation strategy, freedom to operate analysis, monetization, the Hatch-Waxman Act, Abbreviated New Drug Application (ANDA) disputes, trade secrets, and advising on acquisitions and other corporate restructuring.
Scott’s clients span a wide variety of industries and technologies, including leading innovative pharmaceutical companies, genetically modified seed manufacturers, food processors, multinational defense contractors, telecommunications providers, data trading platforms, gaming platforms, and other hardware- and software-based start-ups. In addition to his corporate clients, Scott represents, pro bono, disabled veterans in civil matters and indigent defendants in criminal cases.
Scott has worked closely with IP Spring on client matters for the past five years and became a Member of IP Spring in December 2020, when it merged with Ballast IP Law, the patent boutique he founded in 2015. Before founding Ballast IP Law, Scott was a Partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, where his practice included strategic counseling and patent litigation before the U.S. federal district courts, the U.S. Court of Appeals for the Federal Circuit, and the U.S. International Trade Commission (ITC) on behalf of pharmaceutical, biotechnology, transportation and logistics, and telecommunications companies.
Scott received his J.D. from the University of Michigan Law School and his B.S. in Cellular and Molecular Biology from the University of Michigan, where he worked for four years on the Human Genome Project. Following his undergraduate studies, Scott conducted a year of cancer research at the University of Michigan before matriculating at law school. Scott is a member of the State Bar of California and the Bar of the District of Columbia, and he is admitted to practice before the U.S. Supreme Court, the U.S. Court of Appeals for the Federal Circuit, the U.S. District Court for the Northern District of California, and the U.S. Patent and Trademark Office.